Sila Realty Trust, Inc. (SILA)
NYSEReal EstateReit - Healthcare FacilitiesSnapshot 2026-11-05
$30.360.00%
Close 2026-07-01 · 1-day change
NYSEReal EstateReit - Healthcare FacilitiesSnapshot 2026-11-05
QuarterlyIQ Insights · SILA
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 15.1% |
| Our one-year growth estimate | diamond | 6.7% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-11-05.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 8.4 percentage points more one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-11-05 · Compared with 11 industry peers · Company calendar date is not available
SILA — M&A activity — Changes in Control of Registrant
Dated 2026-07-01
Changes in Control of Registrant. The information provided in the Introductory Note and Items 2.01, 3.01, 3.03, 5.02 and 5.03 of this Current Report on Form 8-K is incorporated herein by reference.
Why it matters: Same-store Cash NOI grew 0.7% in Q1 2026. Faster growth would show stronger rent gains across properties held throughout the year.
Supportive ifA reported same-store Cash NOI result exceeds 0.7% year over year.
Worry ifA reported same-store Cash NOI result is 0.7% or lower year over year.
Why it matters: Blue Owl completed the cash acquisition on July 1, 2026. Sila shares stopped trading, so later filings can show how the assets are run.
Watch forA Blue Owl filing or release names new Sila asset plans, lease changes, or property sales.
Also watch forA Blue Owl filing or release reports no changes to Sila's asset plans, leases, or property sales.
Why it matters: Sila's fixed rent increases averaged 2.1%, excluding leases tied to inflation. Higher rent growth could lift cash income from the portfolio.
Supportive ifA Blue Owl update reports rent growth above 2.1% for Sila's portfolio.
Worry ifA Blue Owl update reports rent growth at or below 2.1%.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$13 on $10,000 · ±0.1% | How much price usually moves either way. |
| Bad day | $175 loss on $10,000 · 1.8% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $1,085 loss on $10,000 · 10.8% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.